Standout Papers
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet (2009)
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia (2003)
- The antioxidants of higher plants (1988)
- Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B (2002)
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia (2010)
- Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet (2009)
- Thirty Years of Research on the Subjective Well-being of Older Americans (1978)
- Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia (2017)
- Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia (2000)
- Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse (2001)
- Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia (2009)
- Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. (1986)
- IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study (2010)
- Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial (2016)
- Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study (2008)
- A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia (2013)
- Association of an Inversion of Chromosome 16 with Abnormal Marrow Eosinophils in Acute Myelomonocytic Leukemia (1983)
Immediate Impact
5 by Nobel laureates 36 from Science/Nature 110 standout
Citing Papers
Acute Myeloid Leukemia
2015 Standout
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
2015 Standout
Works of Richard A. Larson being referenced
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
2008
Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Richard A. Larson | 33343 | 16337 | 11194 | 16902 | 975 | 55.9k | |
| Michael J. Keating | 20959 | 30311 | 8511 | 21086 | 1.1k | 65.3k | |
| Jesús F. San Miguel | 27243 | 7691 | 3592 | 18589 | 989 | 38.9k | |
| Richard M. Stone | 16957 | 6596 | 4850 | 10725 | 730 | 26.5k | |
| Donna Neuberg | 12077 | 9201 | 5881 | 14045 | 713 | 45.2k | |
| Giuseppe Remuzzi | 10434 | 7746 | 4545 | 15712 | 1.3k | 92.7k | |
| Robert A. Kyle | 33182 | 12253 | 1304 | 34291 | 1.0k | 58.3k | |
| Meletios Α. Dimopoulos | 23206 | 8264 | 1433 | 20698 | 1.7k | 49.6k | |
| Eleftherios P. Diamandis | 5236 | 10841 | 1291 | 16868 | 934 | 43.5k | |
| Kenneth C. Anderson | 41282 | 7644 | 1711 | 46654 | 1.4k | 75.4k | |
| T. Huizinga | 6763 | 3938 | 1498 | 6397 | 1.1k | 48.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...